5-Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure–Activity Relationship and Nitroreductase Activation
Authors:
- Temitayo O. Alegbejo PriceTPTemitayo O. Alegbejo Price
- Daniel G. SilvaDSDaniel G. Silva
- Miguel M. VaidergornMVMiguel M. Vaidergorn
- An MatheeussenAMAn Matheeussen
- Natascha Van PeltNPNatascha Van Pelt
- Guy CaljonGuy Caljon
- Kevin D. ReadKRKevin D. Read
- José L. Medina-FrancoJMJosé L. Medina-Franco
- M. Cristina NonatoMNM. Cristina Nonato
- Flavio S EmeryFEFlavio S Emery
Open Access
- 26 May 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (6) , 1398-1406
Abstract
Neglected tropical diseases such as Chagas disease remain poorly served by current chemotherapies due to toxicity and the emergence of drug resistance. Nitroaromatic compounds represent an established antitrypanosomal strategy, relying on bioactivation by Trypanosoma type I nitroreductases. In this study, a fragment-based design approach was applied to the nitroaromatic drugs nifurtimox and benznidazole to generate a novel hybrid scaffold, (E)-N-benzyl-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (1). A series of twenty-two analogues was synthesized by modifying the benzylamine substituent and evaluated for antitrypanosomal activity and susceptibility to nitroreductase I-mediated activation and early ADME properties. Among the series, (E)-N-(4-methylbenzyl)-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (3) and (1) exhibited potent anti-T. cruzi activity (0.14 μM and 0.23 μM), anti-T. b. brucei activity (0.59 ± 0.03 μM and 29.3 ± 15.6 μM), and anti-T. b. rhodesiense (0.87 ± 0.8 μM and 7.44 ± 1.00 μM) in parasite cultures. These findings identify this chemotype as a promising starting point for the further development of nitroreductase-activated therapeutics for Trypanosomiasis disease.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (5R01AI160379-04)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (317060/2021-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (443750/2023-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq-TWAS 163813/2018-3)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/15532-1)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2021/10084-3)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2021/13237-5)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2022/035210)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/08603-0)
- The World Academy of Sciences (CNPq-TWAS 163813/2018-3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 36 references indexed in Scilit:
- Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazoleEuropean Journal of Medicinal Chemistry, 2023
- Trypanosoma cruzi nitroreductase: Structural features and interaction with biological membranesInternational Journal of Biological Macromolecules, 2022
- WHO's 2021–30 roadmap for neglected tropical diseasesThe Lancet Microbe, 2021
- Design, synthesis, and biological activity of novel semicarbazones as potent Ryanodine receptor1 inhibitors of Alzheimer’s diseaseBioorganic & Medicinal Chemistry, 2021
- Fexinidazole: First Global ApprovalDrugs, 2019
- Investigating the structure-activity relationships of N’ -[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compoundsEuropean Journal of Medicinal Chemistry, 2018
- Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotesExperimental Parasitology, 2016
- Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitorsBioorganic & Medicinal Chemistry, 2013
- The structure of Escherichia coli nitroreductase complexed with nicotinic acid: three crystal forms at 1.7 Å, 1.8 Å and 2.4 Å resolutionJournal of Molecular Biology, 2001
- Reductive alkylation of urea: A practical route to substituted ureasTetrahedron Letters, 1998